Role of the gut microbiota in defining human health

References

• Bäckhed F, Manchester JK, Semenkovich CF, Gordon JI. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc. Natl Acad. Sci. USA104(3), 979–984 (2007).
   PubMed Web of Science ®Google Scholar
• Bäckhed F, Ley RE, Sonnenburg JL, Peterson DA, Gordon JI. Host–bacterial mutualism in the human intestine. Science307(5717), 1915–1920 (2005).
   PubMed Web of Science ®Google Scholar
• Blaut M, Clavel T. Metabolic diversity of the intestinal microbiota: implications for health and disease. J. Nutr.137(3), 751S–755S (2007).
   PubMed Web of Science ®Google Scholar
• De La Cochetière M, Durand T, Lalande V, Petit J, Potel G, Beaugerie L. Effect of antibiotic therapy on human fecal microbiota and the relation to the development of Clostridium difficile. Microb. Ecol.56(3), 395–402 (2008).
   PubMed Web of Science ®Google Scholar
• Dicksved J, Halfvarson J, Rosenquist M et al. Molecular analysis of the gut microbiota of identical twins with Crohn’s disease. ISME J.2(7), 716–727 (2008).
   PubMed Web of Science ®Google Scholar
• Ley RE, Bäckhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon JI. Obesity alters gut microbial ecology. Proc. Natl Acad. Sci. USA102(31), 11070–11075 (2005).
   PubMed Web of Science ®Google Scholar
• Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology: human gut microbes associated with obesity. Nature444(7122), 1022–1023 (2006).
   PubMed Web of Science ®Google Scholar
• Li M, Wang B, Zhang M et al. Symbiotic gut microbes modulate human metabolic phenotypes. Proc. Natl Acad. Sci. USA105(6), 2117–2122 (2008).
   PubMed Web of Science ®Google Scholar
• Manichanh C, Rigottier-Gois L, Bonnaud E et al. Reduced diversity of faecal microbiota in Crohn’s disease revealed by a metagenomic approach. Gut55(2), 205–211 (2006).
   PubMed Web of Science ®Google Scholar
• Marchesi JR, Holmes E, Khan F et al. Rapid and noninvasive metabonomic characterization of inflammatory bowel disease. J. Proteome Res.6(2), 546–551 (2007).
   PubMed Web of Science ®Google Scholar
• Palmer C, Bik EM, Digiulio DB, Relman DA, Brown PO. Development of the human infant intestinal microbiota. PLoS Biol.5(7), e177 (2007).
   PubMed Web of Science ®Google Scholar
• Roesch LFW, Lorca GL, Casella G et al. Culture-independent identification of gut bacteria correlated with the onset of diabetes in a rat model. ISME J.3(5), 536–548 (2009).
   PubMed Web of Science ®Google Scholar
• Romick-Rosendale LE, Goodpaster AM, Hanwright PJ et al. NMR-based metabonomics analysis of mouse urine and fecal extracts following oral treatment with the broad-spectrum antibiotic enrofloxacin (Baytril). Magn. Reson. Chem.47(S1), S36–S46 (2009).
   PubMed Web of Science ®Google Scholar
• Scanlan PD, Shanahan F, Clune Y et al. Culture-independent analysis of the gut microbiota in colorectal cancer and polyposis. Environ. Microbiol.10(3), 789–798 (2008).
   PubMed Web of Science ®Google Scholar
• Schumann A, Nutten S, Donnicola D et al. Neonatal antibiotic treatment alters gastrointestinal tract developmental gene expression and intestinal barrier transcriptome. Physiol. Genomics23(2), 235–245 (2005).
   PubMed Web of Science ®Google Scholar
• Turnbaugh PJ, Hamady M, Yatsunenko T et al. A core gut microbiome in obese and lean twins. Nature457(7228), 480–484 (2009).
   PubMed Web of Science ®Google Scholar
• Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature444(7122), 1027–1031 (2006).
   PubMed Web of Science ®Google Scholar
• Collins S, Denou E, Verdu E, Bercik P. The putative role of the intestinal microbiota in the irritable bowel syndrome. Dig. Liver Dis.41(12), 850–853 (2009).
   PubMedGoogle Scholar
• Dethlefsen L, Huse S, Sogin ML, Relman DA. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol.6(11), e280 (2008).
   PubMed Web of Science ®Google Scholar
• Harris JK, De Groote MA, Sagel SD et al. Molecular identification of bacteria in bronchoalveolar lavage fluid from children with cystic fibrosis. Proc. Natl Acad. Sci. USA104(51), 20529–20533 (2007).
   PubMed Web of Science ®Google Scholar
• Hyman RW, Fukushima M, Diamond L, Kumm J, Giudice LC, Davis RW. Microbes on the human vaginal epithelium. Proc. Natl Acad. Sci. USA102(22), 7952–7957 (2005).
   PubMed Web of Science ®Google Scholar
• Sibley CD, Parkins MD, Rabin HR, Duan K, Norgaard JC, Surette MG. A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patients. Proc. Natl Acad. Sci. USA105(39), 15070–15075 (2008).
   PubMed Web of Science ®Google Scholar
• Yi S, Leiqiong C, Jianqian T, Chen X. Preliminary characterization of vaginal microbiota in healthy Chinese women using cultivation-independent methods. J. Obstet. Gynaecol. Res.35(3), 525–532 (2009).
   PubMed Web of Science ®Google Scholar
• Zhou X, Brown CJ, Abdo Z et al. Differences in the composition of vaginal microbial communities found in healthy Caucasian and black women. ISME J.1(2), 121–133 (2007).
   PubMed Web of Science ®Google Scholar
• Kumar PS, Leys EJ, Bryk JM, Martinez FJ, Moeschberger ML, Griffen AL. Changes in periodontal health status are associated with bacterial community shifts as assessed by quantitative 16S cloning and sequencing. J. Clin. Microbiol.44(10), 3665–3673 (2006).
   PubMed Web of Science ®Google Scholar
• Sakamoto M, Huang Y, Ohnishi M, Umeda M, Ishikawa I, Benno Y. Changes in oral microbial profiles after periodontal treatment as determined by molecular analysis of 16S rRNA genes. J. Med. Microbiol.53(Pt 6), 563–571 (2004).
   PubMed Web of Science ®Google Scholar
• Jenzsch A, Eick S, Rassoul F, Purschwitz R, Jentsch H. Nutritional intervention in patients with periodontal disease: clinical, immunological and microbiological variables during 12 months. Br. J. Nutr.101(6), 879–885 (2009).
   PubMed Web of Science ®Google Scholar
• Branch-Mays GL, Dawson DR, Gunsolley JC et al. The effects of a calorie-reduced diet on periodontal inflammation and disease in a non-human primate model. J. Periodontol.79(7), 1184–1191 (2008).
   PubMed Web of Science ®Google Scholar
• Reynolds MA, Dawson DR, Novak KF et al. Effects of caloric restriction on inflammatory periodontal disease. Nutrition25(1), 88–97 (2009).
   PubMed Web of Science ®Google Scholar
• Cani PD, Amar J, Iglesias MA et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes56(7), 1761–1772 (2007).
   PubMed Web of Science ®Google Scholar
• Hildebrandt MA, Hoffmann C, Sherrill-Mix SA et al. High-fat diet determines the composition of the murine gut microbiome independently of obesity. Gastroenterology137(5), 1716–1724.e1–2 (2009).
   PubMed Web of Science ®Google Scholar
• Turnbaugh PJ, Bäckhed F, Fulton L, Gordon JI. Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe3(4), 213–223 (2008).
   PubMed Web of Science ®Google Scholar
• Nadal I, Santacruz A, Marcos A et al. Shifts in clostridia, bacteroides and immunoglobulin-coating fecal bacteria associated with weight loss in obese adolescents. Int. J. Obes.33(7), 758–767 (2008).
   Web of Science ®Google Scholar
• Dong Y, Manfredini F, Dimopoulos G. Implication of the mosquito midgut microbiota in the defense against malaria parasites. PLoS Pathog.5(5), e1000423 (2009).
   PubMed Web of Science ®Google Scholar
• Lawley TD, Bouley DM, Hoy YE, Gerke C, Relman DA, Monack DM. Host transmission of Salmonella enterica serovar typhimurium is controlled by virulence factors and indigenous intestinal microbiota. Infect. Immun.76(1), 403–416 (2008).
   PubMed Web of Science ®Google Scholar
• Lawley TD, Clare S, Walker AW et al. Antibiotic treatment of Clostridium difficile carrier mice triggers a supershedder state, spore-mediated transmission, and severe disease in immunocompromised hosts. Infect. Immun.77(9), 3661–3669 (2009).
   PubMed Web of Science ®Google Scholar
• Ivanov II, Atarashi K, Manel N et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell139(3), 485–498 (2009).
   PubMed Web of Science ®Google Scholar
• Kobayashi T, Okamoto S, Hisamatsu T et al. IL23 differentially regulates the Th1/Th17 balance in ulcerative colitis and Crohn’s disease. Gut57(12), 1682–1689 (2008).
   PubMed Web of Science ®Google Scholar
• Chow J, Mazmanian SK. Getting the bugs out of the immune system: do bacterial microbiota “fix” intestinal T cell responses? Cell Host Microbe5(1), 8–12 (2009).
   PubMed Web of Science ®Google Scholar
• Ege MJ, Bieli C, Frei R et al. Prenatal farm exposure is related to the expression of receptors of the innate immunity and to atopic sensitization in school-age children. J. Allergy Clin. Immunol.117(4), 817–823 (2006).
   PubMed Web of Science ®Google Scholar
• Penders J, Thijs C, Vink C et al. Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics118(2), 511–521 (2006).
   PubMed Web of Science ®Google Scholar
• Wegienka G, Havstad S, Zoratti EM et al. Regulatory T cells in prenatal blood samples: variability with pet exposure and sensitization. J. Reprod. Immunol.81(1), 74–81 (2009).
   PubMed Web of Science ®Google Scholar
• Schaub B, Liu J, Höppler S et al. Maternal farm exposure modulates neonatal immune mechanisms through regulatory T cells. J. Allergy Clin. Immunol.123(4), 774–782 (2009).
   PubMedGoogle Scholar
• Debarry J, Garn H, Hanuszkiewicz A et al.Acinetobacter lwoffii and Lactococcus lactis strains isolated from farm cowsheds possess strong allergy-protective properties. J. Allergy Clin. Immunol.119(6), 1514–1521 (2007).
   PubMed Web of Science ®Google Scholar
• de Meer G, Janssen NAH, Brunekreef B. Early childhood environment related to microbial exposure and the occurrence of atopic disease at school age. Allergy60(5), 619–625 (2005).
   PubMed Web of Science ®Google Scholar
• Duramad P, Harley K, Lipsett M et al. Early environmental exposures and intracellular Th1/Th2 cytokine profiles in 24-month-old children living in an agricultural area. Environ. Health Perspect.114(12), 1916–1922 (2006).
   PubMed Web of Science ®Google Scholar
• Aichbhaumik N, Zoratti EM, Strickler R et al. Prenatal exposure to household pets influences fetal immunoglobulin E production. Clin. Exp. Allergy38(11), 1787–1794 (2008).
   PubMed Web of Science ®Google Scholar
• Prescott SL, Macaubas C, Holt BJ et al. Transplacental priming of the human immune system to environmental allergens: universal skewing of initial T cell responses toward the Th2 cytokine profile. J. Immunol.160(10), 4730–4737 (1998).
   PubMed Web of Science ®Google Scholar
• Bergmann RL, Edenharter G, Bergmann KE et al. Predictability of early atopy by cord blood-IgE and parental history. Clin. Exp. Allergy,27, 752–760 (1997).
   PubMed Web of Science ®Google Scholar
• Illi S, von Mutius E, Lau S et al. The pattern of atopic sensitization is associated with the development of asthma in childhood. J. Allergy Clin. Immunol.108(5), 709–714 (2001).
   PubMed Web of Science ®Google Scholar
• Tariq SM, Arshad SH, Matthews SM, Hakim EA. Elevated cord serum IgE increases the risk of aeroallergen sensitization without increasing respiratory allergic symptoms in early childhood. Clin. Exp. Allergy29(8), 1042–1048 (1999).
   PubMed Web of Science ®Google Scholar
• McKeever TM, Lewis SA, Smith C, Hubbard R. The importance of prenatal exposures on the development of allergic disease: a birth cohort study using the West Midlands general practice database. Am. J. Respir. Crit. Care Med.166(6), 827–832 (2002).
   PubMed Web of Science ®Google Scholar
• Han YW, Shen T, Chung P, Buhimschi IA, Buhimschi CS. Uncultivated bacteria as etiologic agents of intra-amniotic inflammation leading to preterm birth. J. Clin. Microbiol.47(1), 38–47 (2009).
   PubMed Web of Science ®Google Scholar
• DiGiulio DB, Romero R, Amogan HP et al. Microbial prevalence, diversity and abundance in amniotic fluid during preterm labor: a molecular and culture-based investigation. PLoS One3(8), e3056 (2008).
   PubMed Web of Science ®Google Scholar
• Conly JM, Stein K, Worobetz L, Rutledge-Harding S. The contribution of vitamin K2 (menaquinones) produced by the intestinal microflora to human nutritional requirements for vitamin K. Am. J. Gastroenterol.89(6), 915–923 (1994).
   PubMed Web of Science ®Google Scholar
• Hill MJ. Intestinal flora and endogenous vitamin synthesis. Eur. J. Cancer Prev.6(2), S43–S45 (1997).
   PubMed Web of Science ®Google Scholar
• Xu J, Bjursell MK, Himrod J et al. A genomic view of the human–Bacteroides thetaiotaomicron symbiosis. Science299(5615), 2074–2076 (2003).
   PubMed Web of Science ®Google Scholar
• Michelsen KS, Arditi M. Toll-like receptors and innate immunity in gut homeostasis and pathology. Curr. Opin. Hematol.14(1), 48–54 (2007).
   PubMed Web of Science ®Google Scholar
• Rakoff-Nahoum S, Medzhitov R. Innate immune recognition of the indigenous microbial flora. Muc. Immunol.1(Suppl. 1), S10–S14 (2008).
   Web of Science ®Google Scholar
• Kett K, Baklien K, Bakken A, Kral JG, Fausa O, Brandtzaeg P. Intestinal B-cell isotype response in relation to local bacterial load: evidence for immunoglobulin A subclass adaptation. Gastroenterology109(3), 819–825 (1995).
   PubMed Web of Science ®Google Scholar
• Apperloo-Renkema HZ, Jagt TG, Tonk RH, van der Waaij D. Healthy individuals possess circulating antibodies against their indigenous faecal microflora as well as against allogenous faecal microflora: an immunomorphometrical study. Epidemiol. Infect.111(2), 273–285 (1993).
   PubMed Web of Science ®Google Scholar
• Kimura K, McCartney AL, McConnell MA, Tannock GW. Analysis of fecal populations of bifidobacteria and lactobacilli and investigation of the immunological responses of their human hosts to the predominant strains. Appl. Environ. Microbiol.63(9), 3394–3398 (1997).
   PubMed Web of Science ®Google Scholar
• Kawai T, Akira S. Pathogen recognition with Toll-like receptors. Curr. Opin Immunol.17(4), 338–344 (2005).
   PubMed Web of Science ®Google Scholar
• Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R. Recognition of commensal microflora by Toll-like receptors is required for intestinal homeostasis. Cell118(2), 229–241 (2004).
   PubMed Web of Science ®Google Scholar
• Butler JE, Weber P, Sinkora M et al. Antibody repertoire development in fetal and neonatal piglets. VIII. Colonization is required for newborn piglets to make serum antibodies to T-dependent and type 2 T-independent antigens. J. Immunol.169(12), 6822–6830 (2002).
   PubMed Web of Science ®Google Scholar
• Cash HL, Whitham CV, Behrendt CL, Hooper LV. Symbiotic bacteria direct expression of an intestinal bactericidal lectin. Science313(5790), 1126–1130 (2006).
   PubMed Web of Science ®Google Scholar
• Hazebrouck S, Przybylski-Nicaise L, Ah-Leung S et al. Allergic sensitization to bovine β-lactoglobulin: comparison between germ-free and conventional BALB/c mice. Int. Arch. Allergy Immunol.148(1), 65–72 (2009).
   PubMed Web of Science ®Google Scholar
• Hrncir T, Stepankova R, Kozakova H, Hudcovic T, Tlaskalova-Hogenova H. Gut microbiota and lipopolysaccharide content of the diet influence development of regulatory T cells: studies in germ-free mice. BMC Immunol.9, 65 (2008).
   PubMed Web of Science ®Google Scholar
• Macpherson AJ, Gatto D, Sainsbury E, Harriman GR, Hengartner H, Zinkernagel RM. A primitive T cell-independent mechanism of intestinal mucosal IgA responses to commensal bacteria. Science288(5474), 2222–2226 (2000).
   PubMed Web of Science ®Google Scholar
• Wang Y, McCusker C. Neonatal exposure with LPS and/or allergen prevents experimental allergic airways disease: development of tolerance using environmental antigens. J. Allergy Clin. Immunol.118(1), 143–151 (2006).
   PubMed Web of Science ®Google Scholar
• Cebra JJ. Influences of microbiota on intestinal immune system development. Am. J. Clin. Nutr.69(5), 1046S–1051S (1999).
   PubMed Web of Science ®Google Scholar
• Hooper LV, Wong MH, Thelin A, Hansson L, Falk PG, Gordon JI. Molecular analysis of commensal host–microbial relationships in the intestine. Science291(5505), 881–884 (2001).
   PubMed Web of Science ®Google Scholar
• Penders J, Stobberingh EE, van den Brandt PA, Thijs C. The role of the intestinal microbiota in the development of atopic disorders. Allergy62(11), 1223–1236 (2007).
   PubMed Web of Science ®Google Scholar
• Hooper LV, Stappenbeck TS, Hong CV, Gordon JI. Angiogenins: a new class of microbicidal proteins involved in innate immunity. Nat. Immunol.4(3), 269–273 (2003).
   PubMed Web of Science ®Google Scholar
• Penders J, Thijs C, van den Brandt PA et al. Gut microbiota composition and development of atopic manifestations in infancy: the KOALA Birth Cohort Study. Gut56(5), 661–667 (2007).
   PubMed Web of Science ®Google Scholar
• Alenius H, Pakarinen J, Saris O et al. Contrasting immunological effects of two disparate dusts – preliminary observations. Int. Arch. Allergy Immunol.149(1), 81–90 (2009).
   PubMed Web of Science ®Google Scholar
• Macdonald TT, Monteleone G. Immunity, inflammation, and allergy in the gut. Science307(5717), 1920–1925 (2005).
   PubMed Web of Science ®Google Scholar
• Schaub B, Liu J, Schleich I, Hoppler S, Sattler C, von Mutius E. Impairment of T helper and T regulatory cell responses at birth. Allergy63(11), 1438–1447 (2008).
   PubMed Web of Science ®Google Scholar
• Strachan DP. Hay fever, hygiene, and household size. Br. Med. J.299(6710), 1259–1260 (1989).
   PubMed Web of Science ®Google Scholar
• Yoo J, Tcheurekdjian H, Lynch SV, Cabana M, Boushey HA. Microbial manipulation of immune function for asthma prevention: inferences from clinical trials. Proc. Am. Thorac. Soc.4(3), 277–282 (2007).
   PubMedGoogle Scholar
• Thavagnanam S, Fleming J, Bromley A, Shields MD, Cardwell CR. A meta-analysis of the association between Caesarean section and childhood asthma. Clin. Exp. Allergy.38(4), 629–633 (2008).
   PubMed Web of Science ®Google Scholar
• Johnson CC, Ownby DR, Alford SH et al. Antibiotic exposure in early infancy and risk for childhood atopy. J. Allergy Clin. Immunol.115(6), 1218–1224 (2005).
   PubMed Web of Science ®Google Scholar
• Tannock GW, Fuller R, Smith SL, Hall MA. Plasmid profiling of members of the family Enterobacteriaceae, Lactobacilli, and Bifidobacteria to study the transmission of bacteria from mother to infant. J. Clin. Microbiol.28(6), 1225–1228 (1990).
   PubMed Web of Science ®Google Scholar
• Kelly D, Campbell JI, King TP et al. Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-γ and RelA. Nat. Immunol.5(1), 104–112 (2004).
   PubMed Web of Science ®Google Scholar
• Corr SC, Hill C, Gahan CG. Chapter 1 understanding the mechanisms by which probiotics inhibit gastrointestinal pathogens. Adv. Food Nutr. Res.56, 1–15 (2009).
   PubMedGoogle Scholar
• Adlerberth I, Hanson LA, Wold AE. Ontogeny of the intestinal flora. In: Development of the Gastrointestinal Tract. Sanderson I, Walker W (Eds). BC Decker, Hamilton, ON, Canada, 279–292 (1999).
   Google Scholar
• Wagner CL, Taylor SN, Johnson D. Host factors in amniotic fluid and breast milk that contribute to gut maturation. Clin. Rev. Allergy Immunol.34(2), 191–204 (2008).
   PubMed Web of Science ®Google Scholar
• Kramer DR, Cebra JJ. Role of maternal antibody in the induction of virus specific and bystander IgA responses in Peyer’s patches of suckling mice. Int. Immunol.7(6), 911–918 (1995).
   PubMed Web of Science ®Google Scholar
• Kramer DR, Cebra JJ. Early appearance of ‘natural’ mucosal IgA responses and germinal centers in suckling mice developing in the absence of maternal antibodies. J. Immunol.154(5), 2051–2062 (1995).
   PubMed Web of Science ®Google Scholar
• Bollinger RR, Everett ML, Palestrant D, Love SD, Lin SS, Parker W. Human secretory immunoglobulin A may contribute to biofilm formation in the gut. Immunology109(4), 580–587 (2003).
   PubMed Web of Science ®Google Scholar
• Bollinger RR, Everett ML, Wahl SD, Lee Y-H, Orndorff PE, Parker W. Secretory IgA and mucin-mediated biofilm formation by environmental strains of Escherichia coli: role of type 1 pili. Mol. Immunol.43(4), 378–387 (2006).
   PubMed Web of Science ®Google Scholar
• Inoue R, Otsuka M, Ushida K. Development of intestinal microbiota in mice and its possible interaction with the evolution of luminal IgA in the intestine. Exp. Anim.54(5), 437–445 (2005).
   PubMed Web of Science ®Google Scholar
• Rautava S, Walker WA. Academy of Breastfeeding Medicine founder’s lecture 2008: breastfeeding – an extrauterine link between mother and child. Breastfeed. Med.4(1), 3–10 (2009).
   PubMed Web of Science ®Google Scholar
• Ruiz-Palacios GM, Calva JJ, Pickering LK et al. Protection of breast-fed infants against Campylobacter diarrhea by antibodies in human milk. J. Pediatr.116(5), 707–713 (1990).
   PubMed Web of Science ®Google Scholar
• McGuire W, Anthony MY. Donor human milk versus formula for preventing necrotising enterocolitis in preterm infants: systematic review. Arch. Dis. Child. Fetal Neonatal Ed.88(1), F11–F14 (2003).
   PubMed Web of Science ®Google Scholar
• Owen CG, Martin RM, Whincup PH, Smith GD, Cook DG. Effect of infant feeding on the risk of obesity across the life course: a quantitative review of published evidence. Pediatrics115(5), 1367–1377 (2005).
   PubMed Web of Science ®Google Scholar
• Owen CG, Martin RM, Whincup PH, Smith GD, Cook DG. Does breastfeeding influence risk of type 2 diabetes in later life? A quantitative analysis of published evidence. Am. J. Clin. Nutr.84(5), 1043–1054 (2006).
   PubMed Web of Science ®Google Scholar
• Songjinda P, Nakayama J, Tateyama A et al. Differences in developing intestinal microbiota between allergic and non-allergic infants: a pilot study in Japan. Biosci. Biotech. Bioch.71(9), 2338–2342 (2007).
   PubMed Web of Science ®Google Scholar
• Klaassens ES, Boesten RJ, Haarman M et al. Mixed-species genomic microarray analysis of fecal samples reveals differential transcriptional responses of bifidobacteria in breast- and formula-fed infants. Appl. Environ. Microbiol.75(9), 2668–2676 (2009).
   PubMed Web of Science ®Google Scholar
• He F, Morita H, Ouwehand AC et al. Stimulation of the secretion of pro-inflammatory cytokines by Bifidobacterium strains. Microbiol. Immunol.46(11), 781–785 (2002).
   PubMed Web of Science ®Google Scholar
• Ménard S, Candalh C, Bambou JC, Terpend K, Cerf-Bensussan N, Heyman M. Lactic acid bacteria secrete metabolites retaining anti-inflammatory properties after intestinal transport. Gut53(6), 821–828 (2004).
   PubMed Web of Science ®Google Scholar
• Heuvelin E, Lebreton C, Grangette C, Pot B, Cerf-Bensussan N, Heyman M. Mechanisms involved in alleviation of intestinal inflammation by Bifidobacterium breve soluble factors. PLoS One4(4), e5184 (2009).
   PubMed Web of Science ®Google Scholar
• Sela DA, Chapman J, Adeuya A et al. The genome sequence of Bifidobacterium longum subsp. infantis reveals adaptations for milk utilization within the infant microbiome. Proc. Natl Acad. Sci. USA105(48), 18964–18969 (2008).
   PubMed Web of Science ®Google Scholar
• Yang HY, Liu SL, Ibrahim SA et al. Oral administration of live Bifidobacterium substrains isolated from healthy centenarians enhanced immune function in BALB/c mice. Nutr. Res.29(4), 281–289 (2009).
   PubMed Web of Science ®Google Scholar
• Sjögren YM, Jenmalm MC, Böttcher MF, Björkstén B, Sverremark-Ekström E. Altered early infant gut microbiota in children developing allergy up to 5 years of age. Clin. Exp. Allergy39(4), 518–526 (2009).
   PubMed Web of Science ®Google Scholar
• Remes ST, Koskela HO, Iivanainen K, Pekkanen J. Allergen-specific sensitization in asthma and allergic diseases in children: the study on farmers’ and non-farmers’ children. Clin. Exp. Allergy35(2), 160–166 (2005).
   PubMed Web of Science ®Google Scholar
• von Ehrenstein OS, von Mutius E, Illi S, Baumann L, Böhm O, von Kries R. Reduced risk of hay fever and asthma among children of farmers. Clin. Exp. Allergy30(2), 187–193 (2000).
   PubMed Web of Science ®Google Scholar
• Gori A, Tincati C, Rizzardini G et al. Early impairment of gut function and gut flora supporting a role for alteration of gastrointestinal mucosa in human immunodeficiency virus pathogenesis. J. Clin. Microbiol.46(2), 757–758 (2008).
   PubMed Web of Science ®Google Scholar
• Barman M, Unold D, Shifley K et al. Enteric salmonellosis disrupts the microbial ecology of the murine gastrointestinal tract. Infect. Immun.76(3), 907–915 (2008).
   PubMed Web of Science ®Google Scholar
• Baumgart M, Dogan B, Rishniw M et al. Culture independent analysis of ileal mucosa reveals a selective increase in invasive Escherichia coli of novel phylogeny relative to depletion of Clostridiales in Crohn’s disease involving the ileum. ISME J.1(5), 403–418 (2007).
   PubMed Web of Science ®Google Scholar
• Frank DN, St. Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc. Natl Acad. Sci. USA104(34), 13780–13785 (2007).
   PubMed Web of Science ®Google Scholar
• Gophna U, Sommerfeld K, Gophna S, Doolittle WF, Veldhuyzen van Zanten SJ. Differences between tissue-associated intestinal microfloras of patients with Crohn’s disease and ulcerative colitis. J. Clin. Microbiol.44(11), 4136–4141 (2006).
   PubMed Web of Science ®Google Scholar
• Kassinen A, Krogius-Kurikka L, Mäkivuokko H et al. The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterology133(1), 24–33 (2007).
   PubMed Web of Science ®Google Scholar
• Koh AY, Köhler JR, Coggshall KT, Van Rooijen N, Pier GB. Mucosal damage and neutropenia are required for Candida albicans dissemination. PLoS Pathog.4(2), e35 (2008).
   PubMed Web of Science ®Google Scholar
• Lupp C, Robertson ML, Wickham ME et al. Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae. Cell Host Microbe2(2), 119–129 (2007).
   PubMed Web of Science ®Google Scholar
• Martinez-Medina M, Aldeguer X, Lopez-Siles M et al. Molecular diversity of Escherichia coli in the human gut: new ecological evidence supporting the role of adherent-invasive E. coli (AIEC) in Crohn’s disease. Inflamm. Bowel Dis.15(6), 872–882 (2009).
   PubMed Web of Science ®Google Scholar
• Nadal I, Donant E, Ribes-Koninckx C, Calabuig M, Sanz Y. Imbalance in the composition of the duodenal microbiota of children with coeliac disease. J. Med. Microbiol.56(12), 1669–1674 (2007).
   PubMed Web of Science ®Google Scholar
• Ott SJ, Musfeldt M, Ullmann U, Hampe J, Schreiber S. Quantification of intestinal bacterial populations by real-time PCR with a universal primer set and minor groove binder probes: a global approach to the enteric flora. J. Clin. Microbiol.42(6), 2566–2572 (2004).
   PubMed Web of Science ®Google Scholar
• Sokol H, Lepage P, Seksik P, Dore J, Marteau P. Temperature gradient gel electrophoresis of fecal 16S rRNA reveals active Escherichia coli in the microbiota of patients with ulcerative colitis. J. Clin. Microbiol.44(9), 3172–3177 (2006).
   PubMed Web of Science ®Google Scholar
• Sokol H, Pigneur B, Watterlot L et al.Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc. Natl Acad. Sci. USA105(43), 16731–16736 (2008).
   PubMed Web of Science ®Google Scholar
• Stecher B, Robbiani R, Walker AW et al.Salmonella enterica serovar Typhimurium exploits inflammation to compete with the intestinal microbiota. PLoS Biol.5(10), e244 (2007).
   Google Scholar
• Vaahtovuo J, Munukka E, Korkeamäki M, Luukkainen R, Toivanen P. Fecal microbiota in early rheumatoid arthritis. J. Rheumatol.35(8), 1500–1505 (2008).
   PubMed Web of Science ®Google Scholar
• Willing B, Halfvarson J, Dicksved J et al. Twin studies reveal specific imbalances in the mucosa-associated microbiota of patients with ileal Crohn’s disease. Inflamm. Bowel Dis.15(5), 653–660 (2009).
   PubMed Web of Science ®Google Scholar
• Claud EC, Walker WA. Bacterial colonization, probiotics, and necrotizing enterocolitis. J. Clin. Gastroenterol.42(Suppl. 2), S46–S52 (2008).
   PubMed Web of Science ®Google Scholar
• Heilbronn LK, Campbell LV. Adipose tissue macrophages, low grade inflammation and insulin resistance in human obesity. Curr. Pharm. Des.14(12), 1225–1230 (2008).
   PubMed Web of Science ®Google Scholar
• Fuss IJ, Neurath M, Boirivant M et al. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease: Crohn’s disease LP cells manifest increased secretion of IFN-γ, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. J. Immunol.157(3), 1261–1270 (1996).
   PubMed Web of Science ®Google Scholar
• Fujino S, Andoh A, Bamba S et al. Increased expression of interleukin 17 in inflammatory bowel disease. Gut52(1), 65–70 (2003).
   PubMed Web of Science ®Google Scholar
• Fuss IJ, Heller F, Boirivant M et al. Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis. J. Clin. Invest.113(10), 1490–1497 (2004).
   PubMed Web of Science ®Google Scholar
• Heller F, Florian P, Bojarski C et al. Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution. Gastroenterology129(2), 550–564 (2005).
   PubMed Web of Science ®Google Scholar
• Papadakis KA, Targan SR. Role of cytokines in the pathogenesis of inflammatory bowel disease. Annu. Rev. Med.51(1), 289–298 (2000).
   PubMed Web of Science ®Google Scholar
• Hanauer SB. Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities. Inflamm. Bowel Dis.12(5), S3-S9 (2006).
   Google Scholar
• Bollinger RR, Barbas AS, Bush EL, Lin SS, Parker W. Biofilms in the large bowel suggest an apparent function of the human vermiform appendix. J. Theor. Biol.249(4), 826–831 (2007).
   PubMed Web of Science ®Google Scholar
• Danese S, Sans M, Fiocchi C. Inflammatory bowel disease: the role of environmental factors. Autoimmun. Rev.3(5), 394–400 (2004).
   PubMed Web of Science ®Google Scholar
• Baumgart DC, Sandborn WJ. Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet369(9573), 1641–1657 (2007).
   PubMed Web of Science ®Google Scholar
• Fisher SA, Tremelling M, Anderson CA et al. Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn’s disease. Nat. Genet.40(6), 710–712 (2008).
   PubMed Web of Science ®Google Scholar
• Hugot J-P, Chamaillard M, Zouali H et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn’s disease. Nature411(6837), 599–603 (2001).
   PubMed Web of Science ®Google Scholar
• Ogura Y, Bonen DK, Inohara N et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn’s disease. Nature411(6837), 603–606 (2001).
   PubMed Web of Science ®Google Scholar
• Latiano A, Palmieri O, Valvano MR et al. Evaluating the role of the genetic variations of PTPN22, NFKB1, and FcGRIIIA genes in inflammatory bowel disease: a meta-analysis. Inflamm. Bowel Dis.13(10), 1212–1219 (2007).
   PubMed Web of Science ®Google Scholar
• Hampe J, Franke A, Rosenstiel P et al. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat. Genet.39(2), 207–211 (2007).
   PubMed Web of Science ®Google Scholar
• Rioux JD, Xavier RJ, Taylor KD et al. Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat. Genet.39(5), 596–604 (2007).
   PubMed Web of Science ®Google Scholar
• The Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature447(7145), 661–678 (2007).
   PubMed Web of Science ®Google Scholar
• Glas J, Török H-P, Tonenchi L et al. Role of the NFKB1 -94ins/delATTG promoter polymorphism in IBD and potential interactions with polymorphisms in the CARD15/NOD2, IKBL, and IL-1RN genes. Inflamm. Bowel Dis.12(7), 606–611 (2006).
   PubMed Web of Science ®Google Scholar
• Borm MEA, Bodegraven AA, Mulder CJJ, Kraal G, Bouma G. A NFKB1 promoter polymorphism is involved in susceptibility to ulcerative colitis. Int. J. Immunogenet.32(6), 401–405 (2005).
   PubMed Web of Science ®Google Scholar
• Mirza MM, Fisher SA, Onnie C et al. No association of the NFKB1 promoter polymorphism with ulcerative colitis in a British case control cohort. Gut54(8), 1205–1206 (2005).
   PubMed Web of Science ®Google Scholar
• Karban AS, Okazaki T, Panhuysen CIM et al. Functional annotation of a novel NFKB1 promoter polymorphism that increases risk for ulcerative colitis. Hum. Mol. Genet.13(1), 35–45 (2004).
   PubMed Web of Science ®Google Scholar
• Macfarlane GT, Blackett KL, Nakayama T, Steed H, Macfarlane S. The gut microbiota in inflammatory bowel disease. Curr. Pharm. Des.15(13), 1528–1536 (2009).
   PubMed Web of Science ®Google Scholar
• Tamboli CP, Neut C, Desreumaux P, Colombel JF. Dysbiosis in inflammatory bowel disease. Gut53(1), 1–4 (2004).
   PubMed Web of Science ®Google Scholar
• Conte MP, Schippa S, Zamboni I et al. Gut-associated bacterial microbiota in paediatric patients with inflammatory bowel disease. Gut55(12), 1760–1767 (2006).
   PubMed Web of Science ®Google Scholar
• Hamer HM, Jonkers D, Venema K, Vanhoutvin S, Troost FJ, Brummer RJ. Review article: the role of butyrate on colonic function. Aliment. Pharmacol. Ther.27(2), 104–119 (2008).
   PubMed Web of Science ®Google Scholar
• Pajak B, Orzechowski A, Gajkowska B. Molecular basis of sodium butyrate-dependent proapoptotic activity in cancer cells. Adv. Med. Sci.52, 83–88 (2007).
   PubMed Web of Science ®Google Scholar
• Scheppach W, Weiler F. The butyrate story: old wine in new bottles? Curr. Opin. Clin. Nutr. Metab. Care7(5), 563–567 (2004).
   PubMed Web of Science ®Google Scholar
• Sokol H, Seksik P, Furet JP et al. Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm. Bowel Dis.15(8), 1183–1189 (2009).
   PubMed Web of Science ®Google Scholar
• Jansson J, Willing B, Lucio M et al. Metabolomics reveals metabolic biomarkers of Crohn’s disease. PLoS One4(7), e6386 (2009).
   PubMed Web of Science ®Google Scholar
• Balasubramanian K, Kumar S, Singh RR et al. Metabolism of the colonic mucosa in patients with inflammatory bowel diseases: an in vitro proton magnetic resonance spectroscopy study. Magn. Reson. Imaging27(1), 79–86 (2009).
   PubMed Web of Science ®Google Scholar
• Alm B, Erdes L, Mollborg P et al. Neonatal antibiotic treatment is a risk factor for early wheezing. Pediatrics121(4), 697–702 (2008).
   PubMed Web of Science ®Google Scholar
• Alam S, Mushtaq M. Antibiotic associated diarrhea in children. Indian Pediatr.46(6), 491–496 (2009).
   PubMed Web of Science ®Google Scholar
• Surawicz CM. Antibiotic-associated diarrhea and pseudomembranous colitis: are they less common with poorly absorbed antimicrobials? Chemotherapy51(Suppl. 1), 81–89 (2005).
   PubMed Web of Science ®Google Scholar
• Caramia G. Metchnikoff and the centenary of probiotics: an update of their use in gastroenteric pathology during the age of development. Minerva Pediatr.60(6), 1417–1435 (2008).
   PubMedGoogle Scholar
• Resta-Lenert S, Barrett KE. Live probiotics protect intestinal epithelial cells from the effects of infection with enteroinvasive Escherichia coli (EIEC). Gut52(7), 988–997 (2003).
   PubMed Web of Science ®Google Scholar
• Servin AL, Coconnier MH. Adhesion of probiotic strains to the intestinal mucosa and interaction with pathogens. Best Pract. Res. Clin. Gastroenterol.17(5), 741–754 (2003).
   PubMed Web of Science ®Google Scholar
• Resta-Lenert SC, Barrett KE. Modulation of intestinal barrier properties by probiotics: role in reversing colitis. Ann. NY Acad. Sci.1165, 175–182 (2009).
   PubMed Web of Science ®Google Scholar
• Dembele T, Obdrzalek V, Votava M. Inhibition of bacterial pathogens by lactobacilli. Zentralbl. Bakteriol.288(3), 395–401 (1998).
   PubMedGoogle Scholar
• Ocana VS, Elena Nader-Macias M. Production of antimicrobial substances by lactic acid bacteria II: screening bacteriocin-producing strains with probiotic purposes and characterization of a Lactobacillus bacteriocin. Methods Mol. Biol.268, 347–353 (2004).
   PubMedGoogle Scholar
• Kaila M, Isolauri E, Soppi E, Virtanen E, Laine S, Arvilommi H. Enhancement of the circulating antibody secreting cell response in human diarrhea by a human Lactobacillus strain. Pediatr. Res.32(2), 141–144 (1992).
   PubMed Web of Science ®Google Scholar
• Di Caro S, Tao H, Grillo A et al. Effects of Lactobacillus GG on genes expression pattern in small bowel mucosa. Dig. Liver Dis.37(5), 320–329 (2005).
   PubMedGoogle Scholar
• Dotan I, Rachmilewitz D. Probiotics in inflammatory bowel disease: possible mechanisms of action. Curr. Opin Gastroenterol.21(4), 426–430 (2005).
   PubMed Web of Science ®Google Scholar
• Yan F, Polk DB. Probiotic bacterium prevents cytokine-induced apoptosis in intestinal epithelial cells. J. Biol. Chem.277(52), 50959–50965 (2002).
   PubMed Web of Science ®Google Scholar
• Gibson GR, Roberfroid MB. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J. Nutr.125(6), 1401–1412 (1995).
   PubMed Web of Science ®Google Scholar
• Gibson GR, Probert HM, Loo JV, Rastall RA, Roberfroid MB. Dietary modulation of the human colonic microbiota: updating the concept of prebiotics. Nutr. Res. Rev.17(02), 259–275 (2004).
   PubMed Web of Science ®Google Scholar
• Saulnier DMA, Spinler JK, Gibson GR, Versalovic J. Mechanisms of probiosis and prebiosis: considerations for enhanced functional foods. Curr. Opin. Biotechnol.20(2), 135–141 (2009).
   PubMed Web of Science ®Google Scholar
• Preidis GA, Versalovic J. Targeting the human microbiome with antibiotics, probiotics, and prebiotics: gastroenterology enters the metagenomics era. Gastroenterology136(6), 2015–2031 (2009).
   PubMed Web of Science ®Google Scholar
• Sellon RK, Tonkonogy S, Schultz M et al. Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect. Immun.66(11), 5224–5231 (1998).
   PubMed Web of Science ®Google Scholar
• Taurog JD, Richardson JA, Croft JT et al. The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. J. Exp. Med.180(6), 2359–2364 (1994).
   PubMed Web of Science ®Google Scholar
• Mileti E, Matteoli G, Iliev ID, Rescigno M. Comparison of the immunomodulatory properties of three probiotic strains of lactobacilli using complex culture systems: prediction for in vivo efficacy. PLoS One4(9), e7056 (2009).
   PubMed Web of Science ®Google Scholar
• Fedorak RN. Probiotics in the management of inflammatory bowel diseases? Am. J. Gastroenterol.102(s1), S22–S28 (2007).
   Google Scholar
• Isaacs K, Herfarth H. Role of probiotic therapy in IBD. Inflamm. Bowel Dis.14(11), 1597–1605 (2008).
   PubMed Web of Science ®Google Scholar
• Fellermann K, Wehkamp J, Herrlinger KR, Stange EF. Crohn’s disease: a defensin deficiency syndrome? Eur. J. Gastroenterol. Hepatol.15, 627–634 (2003).
   PubMed Web of Science ®Google Scholar
• Tursi A, Brandimarte G, Giorgetti GM, Forti G, Modeo ME, Gigliobianco A. Low-dose balsalazide plus a high-potency probiotic preparation is more effective than balsalazide alone or mesalazine in the treatment of acute mild-to-moderate ulcerative colitis. Med. Sci. Monit.10(11), PI126–PI131 (2004).
   PubMed Web of Science ®Google Scholar
• Bibiloni R, Fedorak RN, Tannock GW et al. VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis. Am. J. Gastroenterol.100(7), 1539–1546 (2005).
   PubMed Web of Science ®Google Scholar
• Sood A, Midha V, Makharia GK et al. The probiotic preparation, VSL#3 induces remission in patients with mild-to-moderately active ulcerative colitis. Clin. Gastroenterol. H7(11), 1202–1209 (2009).
   PubMed Web of Science ®Google Scholar
• Guslandi M, Giollo P, Testoni PA. A pilot trial of Saccharomyces boulardii in ulcerative colitis. Eur. J. Gastroenterol. Hepatol.15(6), 697–698 (2003).
   PubMed Web of Science ®Google Scholar
• Guslandi M, Mezzi G, Sorghi M, Testoni PA. Saccharomyces boulardii in maintenance treatment of Crohn’s disease. Dig. Dis. Sci.45(7), 1462–1464 (2000).
   PubMed Web of Science ®Google Scholar
• AlFaleh K, Anabrees J, Bassler D. Probiotics reduce the risk of necrotizing enterocolitis in preterm infants: a meta-analysis. Neonatology97(2), 93–99 (2009).
   PubMed Web of Science ®Google Scholar
• Barclay AR, Stenson B, Simpson JH, Weaver LT, Wilson DC. Probiotics for necrotizing enterocolitis: a systematic review. J. Pediatr. Gastroenterol. Nutr.45(5), 569–576 (2007).
   PubMed Web of Science ®Google Scholar
• Bin-Nun A, Bromiker R, Wilschanski M et al. Oral probiotics prevent necrotizing enterocolitis in very low birth weight neonates. J. Pediatr.147(2), 192–196 (2005).
   PubMed Web of Science ®Google Scholar
• Caplan MS. Probiotic and prebiotic supplementation for the prevention of neonatal necrotizing enterocolitis. J. Perinatol.29(S2), S2–S6 (2009).
   Web of Science ®Google Scholar
• Deshpande G, Rao S, Patole S. Probiotics for prevention of necrotising enterocolitis in preterm neonates with very low birthweight: a systematic review of randomised controlled trials. Lancet369(9573), 1614–1620 (2007).
   PubMed Web of Science ®Google Scholar
• Lin H-C, Su B-H, Chen A-C et al. Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants. Pediatrics115(1), 1–4 (2005).
   PubMed Web of Science ®Google Scholar
• Martin CR, Walker WA. Probiotics: role in pathophysiology and prevention in necrotizing enterocolitis. Semin. Perinatol.32(2), 127–137 (2008).
   PubMed Web of Science ®Google Scholar
• Cox MJ, Huang YJ, Fujimura KE et al.Lactobacillus casei abundance is associated with profound shifts in the infant gut microbiome. PLoS One5(1), e8745 (2010).
   PubMed Web of Science ®Google Scholar
• Brodie EL, DeSantis TZ, Joyner DC et al. Application of a high-density oligonucleotide microarray approach to study bacterial population dynamics during uranium reduction and reoxidation. Appl. Environ. Microbiol.72(9), 6288–6298 (2006).
   PubMed Web of Science ®Google Scholar
• Besselink MG, van Santvoort HC, Buskens E et al. Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet371(9613), 651–659 (2008).
   PubMed Web of Science ®Google Scholar
• Kunz AN, Noel JM, Fairchok MP. Two cases of Lactobacillus bacteremia during probiotic treatment of short gut syndrome. J. Pediatr. Gastroenterol. Nutr.38(4), 457–458 (2004).
   PubMed Web of Science ®Google Scholar
• Land MH, Rouster-Stevens K, Woods CR, Cannon ML, Cnota J, Shetty AK. Lactobacillus sepsis associated with probiotic therapy. Pediatrics115(1), 178–181 (2005).
   PubMed Web of Science ®Google Scholar
• Winkler J, Butler R, Symonds E. Fructo-oligosaccharide reduces inflammation in a dextran sodium sulphate mouse model of colitis. Digest. Dis. Sci.52(1), 52–58 (2007).
   PubMed Web of Science ®Google Scholar
• Lewis S, Brazier J, Beard D, Nazem N, Proctor D. Effects of metronidazole and oligofructose on faecal concentrations of sulphate-reducing bacteria and their activity in human volunteers. Scand. J. Gastroenterol.40(11), 1296–1303 (2005).
   PubMed Web of Science ®Google Scholar
• Kanauchi O, Oshima T, Andoh A, Shioya M, Mitsuyama K. Germinated barley foodstuff ameliorates inflammation in mice with colitis through modulation of mucosal immune system. Scand. J. Gastroenterol.43(11), 1346–1352 (2008).
   PubMed Web of Science ®Google Scholar
• Le Leu RK, Hu Y, Brown IL, Woodman RJ, Young GP. Synbiotic intervention of Bifidobacterium lactis and resistant starch protects against colorectal cancer development in rats. Carcinogenesis31(2), 246–251 (2010).
   PubMed Web of Science ®Google Scholar
• Pool-Zobel BL. Inulin-type fructans and reduction in colon cancer risk: review of experimental and human data. Br. J. Nutr.93(Suppl. S1), S73–S90 (2005).
   PubMed Web of Science ®Google Scholar
• Roller M, Pietro Femia A, Caderni G, Rechkemmer G, Watzl B. Intestinal immunity of rats with colon cancer is modulated by oligofructose-enriched inulin combined with Lactobacillus rhamnosus and Bifidobacterium lactis. Br. J. Nutr.92(6), 931–938 (2004).
   PubMed Web of Science ®Google Scholar
• Rowland IR, Rumney CJ, Coutts JT, Lievense LC. Effect of Bifidobacterium longum and inulin on gut bacterial metabolism and carcinogen-induced aberrant crypt foci in rats. Carcinogenesis19(2), 281–285 (1998).
   PubMed Web of Science ®Google Scholar
• Rafter J, Bennett M, Caderni G et al. Dietary synbiotics reduce cancer risk factors in polypectomized and colon cancer patients. Am. J. Clin. Nutr.85(2), 488–496 (2007).
   PubMed Web of Science ®Google Scholar
• Furrie E, Macfarlane S, Kennedy A et al. Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial. Gut54(2), 242–249 (2005).
   PubMed Web of Science ®Google Scholar
• Fujimori S, Tatsuguchi A, Gudis K et al. High dose probiotic and prebiotic cotherapy for remission induction of active Crohn’s disease. J. Gastroenterol. Hepatol.22(8), 1199–1204 (2007).
   PubMed Web of Science ®Google Scholar
• Alfvén T, Braun-Fahrländer C, Brunekreef B et al. Allergic diseases and atopic sensitization in children related to farming and anthroposophic lifestyle – the PARSIFAL study. Allergy61(4), 414–421 (2006).
   PubMed Web of Science ®Google Scholar
• Bråbäck L, Hjern A, Rasmussen F. Trends in asthma, allergic rhinitis and eczema among Swedish conscripts from farming and non-farming environments. A nationwide study over three decades. Clin. Exp. Allergy34(1), 38–43 (2004).
   PubMed Web of Science ®Google Scholar
• Brussee JE, Smit HA, van Strien RT et al. Allergen exposure in infancy and the development of sensitization, wheeze, and asthma at 4 years. J. Allergy Clin. Immunol.115(5), 946–952 (2005).
   PubMed Web of Science ®Google Scholar
• Korppi M, Hyvarinen M, Kotaniemi-Syrjanen A, Piippo-Savolainen E, Reijonen T. Early exposure and sensitization to cat and dog: different effects on asthma risk after wheezing in infancy. Pediatr. Allergy Immunol.19(8), 696–701 (2008).
   PubMed Web of Science ®Google Scholar
• Perzanowski MS, Chew GL, Divjan A et al. Cat ownership is a risk factor for the development of anti-cat IgE but not current wheeze at age 5 years in an inner-city cohort. J. Allergy Clin. Immunol.121(4), 1047–1052 (2008).
   PubMed Web of Science ®Google Scholar
• Radon K, Schulze A, Nowak D. Inverse association between farm animal contact and respiratory allergies in adulthood: protection, underreporting or selection? Allergy61(4), 443–446 (2006).
   PubMed Web of Science ®Google Scholar
• Roponen M, Hyvärinen A, Hirvonen M-R, Keski-Nisula L, Pekkanen J. Change in IFN-γ-producing capacity in early life and exposure to environmental microbes. J. Allergy Clin. Immunol.116(5), 1048–1052 (2005).
   PubMed Web of Science ®Google Scholar
• Schafer T, Stieger B, Polzius R, Krauspe A. Associations between cat keeping, allergen exposure, allergic sensitization and atopic diseases: results from the Children of Lubeck Allergy and Environment Study (KLAUS). Pediatr. Allergy Immunol.20(4), 353–357 (2009).
   PubMed Web of Science ®Google Scholar
• Takkouche B, Gonzalez-Barcala FJ, Etminan M, Fitzgerald M. Exposure to furry pets and the risk of asthma and allergic rhinitis: a meta-analysis. Allergy63(7), 857–864 (2008).
   PubMed Web of Science ®Google Scholar
• Maitra A, Sherriff A, Strachan D, Henderson J. Mode of delivery is not associated with asthma or atopy in childhood. Clin. Exp. Allergy34(9), 1349–1355 (2004).
   PubMed Web of Science ®Google Scholar
• Mikami K, Takahashi H, Kimura M et al. Influence of maternal bifidobacteria on the establishment of bifidobacteria colonizing the gut in infants. Pediatr. Res.65(6), 669–674 (2009).
   PubMed Web of Science ®Google Scholar
• Turroni F, Marchesi JR, Foroni E et al. Microbiomic analysis of the bifidobacterial population in the human distal gut. ISME J.3(6), 745–751 (2009).
   PubMed Web of Science ®Google Scholar
• Campo P, Kalra HK, Levin L et al. Influence of dog ownership and high endotoxin on wheezing and atopy during infancy. J. Allergy Clin. Immunol.118(6), 1271–1278 (2006).
   PubMed Web of Science ®Google Scholar
• Pohlabeln H, Jacobs S, Bohmann J. Exposure to pets and the risk of allergic symptoms during the first 2 years of life. J. Investig. Allergol. Clin. Immunol.17(5), 302–308 (2007).
   PubMed Web of Science ®Google Scholar
• Adlerberth I, Lindberg E, Aberg N et al. Reduced enterobacterial and increased staphylococcal colonization of the infantile bowel: an effect of hygienic lifestyle? Pediatr. Res.59(1), 96–101 (2006).
   PubMed Web of Science ®Google Scholar
• Bertini I, Calabrò A, De Carli V et al. The metabonomic signature of celiac disease. J. Proteome Res.8(1), 170–177 (2008).
   Web of Science ®Google Scholar
• Wen L, Ley RE, Volchkov PY et al. Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature455(7216), 1109–1113 (2008).
   PubMed Web of Science ®Google Scholar
• Dumas M-E, Barton RH, Toye A et al. Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice. Proc. Natl Acad. Sci. USA103(33), 12511–12516 (2006).
   PubMed Web of Science ®Google Scholar
• Brugman S, Klatter FA, Visser JT et al. Antibiotic treatment partially protects against type 1 diabetes in the Bio-Breeding diabetes-prone rat. Is the gut flora involved in the development of type 1 diabetes? Diabetologia49(9), 2105–2108 (2006).
   PubMed Web of Science ®Google Scholar
• Bibiloni R, Membrez M, Chou CJ. Gut microbiota, obesity and diabetes. Ann. Nestle (English ed.)67(1), 39–47 (2009).
   Google Scholar
• Cani P, Neyrinck A, Fava F et al. Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia50(11), 2374–2383 (2007).
   PubMed Web of Science ®Google Scholar
• Cani PD, Bibiloni R, Knauf C et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes57(6), 1470–1481 (2008).
   PubMed Web of Science ®Google Scholar
• Cani PD, Delzenne NM. Gut microflora as a target for energy and metabolic homeostasis. Curr. Opin Clin. Nutr. Metab. Care10(6), 729–734 (2007).
   PubMed Web of Science ®Google Scholar
• Bäckhed F. Changes in intestinal microflora in obesity: cause or consequence? J. Pediatr. Gastroenterol. Nutr.48, S56–S57 (2009).
   PubMed Web of Science ®Google Scholar
• Membrez M, Blancher F, Jaquet M et al. Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice. FASEB J.22(7), 2416–2426 (2008).
   PubMed Web of Science ®Google Scholar
• Monteleone G, Monteleone I, Fina D et al. Interleukin-21 enhances T-helper cell type I signaling and interferon-γ production in Crohn’s disease. Gastroenterology128(3), 687–694 (2005).
   PubMed Web of Science ®Google Scholar
• Bibiloni R, Mangold M, Madsen KL, Fedorak RN, Tannock GW. The bacteriology of biopsies differs between newly diagnosed, untreated, Crohn’s disease and ulcerative colitis patients. J. Med. Microbiol.55(8), 1141–1149 (2006).
   PubMed Web of Science ®Google Scholar
• Macfarlane S, Furrie E, Kennedy A, Cummings JH, Macfarlane GT. Mucosal bacteria in ulcerative colitis. Br. J. Nutr.93(Suppl. S1), S67–S72 (2005).
   PubMed Web of Science ®Google Scholar
• Sokol H, Seksik P, Rigottier-Gois L et al. Specificities of the fecal microbiota in inflammatory bowel disease. Inflamm. Bowel Dis.12(2), 106–111 (2006).
   PubMed Web of Science ®Google Scholar
• Zhang M, Liu B, Zhang Y, Wei H, Lei Y, Zhao L. Structural shifts of mucosa-associated lactobacilli and Clostridium leptum subgroup in patients with ulcerative colitis. J. Clin. Microbiol.45(2), 496–500 (2007).
   PubMed Web of Science ®Google Scholar
• Lin PW, Nasr TR, Stoll BJ. Necrotizing enterocolitis: recent scientific advances in pathophysiology and prevention. Semin. Perinatol.32(2), 70–82 (2008).
   PubMed Web of Science ®Google Scholar
• Henry MCW, Moss RL. Necrotizing enterocolitis. Annu. Rev. Med.60(1), 111–124 (2009).
   PubMed Web of Science ®Google Scholar
• Wang Y, Hoenig JD, Malin KJ et al. 16S rRNA gene-based analysis of fecal microbiota from preterm infants with and without necrotizing enterocolitis. ISME J.3(8), 944–954 (2009).
   PubMed Web of Science ®Google Scholar
• Zhang H, DiBaise JK, Zuccolo A et al. Human gut microbiota in obesity and after gastric bypass. Proc. Natl Acad. Sci. USA106(7), 2365–2370 (2009).
   PubMed Web of Science ®Google Scholar